Your AI-Trained Oncology Knowledge Connection!

Advances in MRD Testing for Informed CRC Treatment : Episode 5

Opinion

Video

March 25, 2024

Colorectal Cancer: MRD Testing in the Community Setting

Author(s):

John L. Marshall, MD,Benjamin Weinberg, MD

Pashtoon Murtaza Kasi, MD, MS, discusses MRD testing practices in the community oncology setting and provides recommendations on the integration of MRD testing into clinical practice.

EP: 1.Treating Colorectal Cancer: Overview of MRD Testing and ctDNA

EP: 2.When is MRD Testing Performed in Colorectal Cancer Treatment?

EP: 3.MRD Testing Platforms in Colorectal Cancer

EP: 4.Testing for MRD in Colorectal Cancer

Now Viewing

EP: 5.Colorectal Cancer: MRD Testing in the Community Setting

EP: 6.Practical Considerations in MRD Testing in CRC

EP: 7.Evolution of MRD Testing in Colorectal Cancer

EP: 8.Patient Profile: A 52-Year-Old Woman With Colorectal Cancer

EP: 9.Colorectal Cancer: Updates from the GALAXY Arm in CIRCULATE-Japan

EP: 10.BESPOKE CRC: Study of ctDNA-Guided Therapy in Colorectal Cancer

EP: 11.Myths Surrounding Liquid Biopsy and ctDNA Testing for MRD

EP: 12.Patient Profile 2: A 35-Year-Old Man With Oligometastatic Colorectal Cancer

EP: 13.Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer

EP: 14.Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer: Part 2

EP: 15.CIRCULATE-NORTH AMERICA and Barriers to Enrollment

EP: 16.MRD Testing in CRC: Gaps in our Understanding and Potential Advancements

EP: 17.Trajectory of CRC Treatment Landscape

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All

Video

Addressing Unmet Needs in HER2+ Metastatic BTC

Apr 18th 2025 - Apr 19th 2026

online-activity

Video

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Apr 17th 2025 - May 23rd 2025

online-activity

Video

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

Apr 17th 2025 - May 23rd 2025

online-activity

Latest Conference Coverage

Overview of iMMagine-1 Trial: Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of R/R MM

Application of Real-World Evidence in Selecting CAR T in R/R MM

Addition of Daratumumab to Lenalidomide Maintenance Boosts MRD-Negative Conversions in Myeloma Following ASCT

Apalutamide Boosts 24-Month OS in Real-World Population With Metastatic Castration-Sensitive Prostate Cancer

View More Latest Conference Coverage

Advertise

About OncLive

Editorial Board

MJH Life Sciences brands

Privacy

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

Colorectal Cancer: MRD Testing in the Community Setting

EP: 1.Treating Colorectal Cancer: Overview of MRD Testing and ctDNA

EP: 2.When is MRD Testing Performed in Colorectal Cancer Treatment?

EP: 3.MRD Testing Platforms in Colorectal Cancer

EP: 4.Testing for MRD in Colorectal Cancer

EP: 5.Colorectal Cancer: MRD Testing in the Community Setting

EP: 6.Practical Considerations in MRD Testing in CRC

EP: 7.Evolution of MRD Testing in Colorectal Cancer

EP: 8.Patient Profile: A 52-Year-Old Woman With Colorectal Cancer

EP: 9.Colorectal Cancer: Updates from the GALAXY Arm in CIRCULATE-Japan

EP: 10.BESPOKE CRC: Study of ctDNA-Guided Therapy in Colorectal Cancer

EP: 11.Myths Surrounding Liquid Biopsy and ctDNA Testing for MRD

EP: 12.Patient Profile 2: A 35-Year-Old Man With Oligometastatic Colorectal Cancer

EP: 13.Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer

EP: 14.Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer: Part 2

EP: 15.CIRCULATE-NORTH AMERICA and Barriers to Enrollment

EP: 16.MRD Testing in CRC: Gaps in our Understanding and Potential Advancements

EP: 17.Trajectory of CRC Treatment Landscape

Newsletter

Latest CME

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Updates and Innovations in Nonopioid Pain Management Strategies for Breast Cancer Patients Postsurgical Intervention

Addressing Unmet Needs in HER2+ Metastatic BTC

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Updates and Innovations in Nonopioid Pain Management Strategies for Breast Cancer Patients Postsurgical Intervention

Addressing Unmet Needs in HER2+ Metastatic BTC

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Updates and Innovations in Nonopioid Pain Management Strategies for Breast Cancer Patients Postsurgical Intervention

Latest Conference Coverage